Requip and Enablex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Requip (ropinirole hydrochloride) and Enablex (darifenacin hydrobromide). Common drug interactions include cardio-respiratory arrest among females and multiple sclerosis relapse among males.

The phase IV clinical study analyzes what interactions people have when they take Requip and Enablex. It is created by eHealthMe based on reports of 53 people who take the same drugs from the FDA, and is updated regularly.

What is Requip?

Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,950 Requip users. Check the latest studies of Requip.

What is Enablex?

Enablex has active ingredients of darifenacin hydrobromide. It is often used in urge incontinence. eHealthMe is studying from 4,934 Enablex users. Check the latest studies of Enablex.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 04, 2026

53 people who take Requip and Enablex together, and have interactions are studied.

Requip and Enablex drug interactions.

What are the common drug interactions of Requip and Enablex, by gender? *:

female:

  1. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  2. Cellulitis (infection under the skin)
  3. Dehydration (dryness resulting from the removal of water)
  4. Diarrhoea
  5. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  6. Dysphagia (a condition in which swallowing is difficult or painful)
  7. Gastric disorder (disease of stomach)
  8. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  9. General physical health deterioration (weak health status)
  10. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)

male:

  1. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  2. Progressive multifocal leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells)
  3. Fall
  4. Hip fracture
  5. Impaired driving ability
  6. Nausea (feeling of having an urge to vomit)
  7. Oedema peripheral (superficial swelling)
  8. Urinary retention (the inability to completely or partially empty the bladder)
  9. Urinary tract infection
  10. Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)

What are the common drug interactions of Requip and Enablex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abortion spontaneous (naturally occurring miscarriage)

40-49:

  1. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  2. Arthralgia (joint pain)
  3. Back pain
  4. Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
  5. Dependence
  6. Drug abuse
  7. Drug ineffective
  8. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  9. Eating disorder
  10. Fall

50-59:

  1. Immune reconstitution syndrome (immune recovery syndrome)
  2. Confusional state
  3. Alanine aminotransferase increased
  4. Alopecia (absence of hair from areas of the body)
  5. Aspartate aminotransferase increased
  6. Blood alkaline phosphatase increased
  7. Cellulitis (infection under the skin)
  8. Chest pain
  9. Decreased appetite
  10. Disorientation (disability in which the senses of time, direction, and recognition of people and places)

60+:

  1. Haematuria (presence of blood in urine)
  2. Dizziness
  3. Myalgia (muscle pain)
  4. Oedema peripheral (superficial swelling)
  5. Pain in extremity
  6. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  7. Renal failure (kidney dysfunction)
  8. Bone disorder
  9. Bone marrow failure
  10. Cardiac failure congestive

What are the existing conditions these people have? *

  1. Pain: 15 people, 28.30%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 14 people, 26.42%
  3. High Blood Pressure: 9 people, 16.98%
  4. Urinary Incontinence (inability to control the flow of urine and involuntary urination): 8 people, 15.09%
  5. Urinary Tract Infection: 7 people, 13.21%
  6. Depression: 7 people, 13.21%
  7. Fibromyalgia (a long-term condition which causes pain all over the body): 7 people, 13.21%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 13.21%
  9. Hypertriglyceridaemia (excess of triglycerides in the blood): 7 people, 13.21%
  10. Mixed Incontinence (a combination of stress and urge incontinence): 7 people, 13.21%

* Approximation only. Some reports may have incomplete information.

Do you take Requip and Enablex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Requip and Enablex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Requip:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Enablex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Requip and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Enablex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ropinirole hydrochloride and darifenacin hydrobromide (the active ingredients of Requip and Enablex, respectively), and Requip and Enablex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: